EQT sells remaining stake in LBX Pharmacy
· EQT Greater China sells remaining 24.78 percent in LBX Pharmacy, a leading discount pharmacy superstore chain in China, at RMB 55.0 per share, 235.2 percent above the IPO price of RMB 16.4 · LBX Pharmacy has experienced strong growth and transformation during EQT’s ownership, leveraging the EQT Network and healthcare sector expertise · LBX Pharmacy’s successful IPO on the Shanghai Stock Exchange in 2015 was the first IPO in China with a foreign private equity fund as control or co-control shareholder The EQT Greater China II fund (“EQT Greater China” or “EQT”) today announced